Cannabis stocks surge on rescheduling news; Aurora Cannabis jumps 16% despite no US strategy. Read why I'm maintaining my ...

Canopy Growth (CGC), Cronos Group (CRON) and Trulieve Cannabis (TCNNF) after reports that U.S. President Donald Trump may ...

Aurora Cannabis posted mixed Q1 FY2026 results, facing sales pressure, covenant issues, and looming German regulatory risks.

Shares of Canopy Growth Corp (NASDAQ:CGC) jumped 19.2% on Monday amid reports that President Donald Trump is considering ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

However, Aurora Cannabis is no Apple: There is very little reason to think the pot grower can reverse course. First, the problems it faced in the Canadian cannabis market largely remain.

When recreational cannabis was legalized, the city of Aurora decided dispensary hours should be 8 a.m. to 10 p.m. "The hype is still there, people are still consuming," said Starbuds Store ...

On the one hand, Aurora's sales declined steeply year over year, with total revenues falling 20% to CA$54.8 million and consumer cannabis sales in particular down a staggering 45%.

Aurora sold about $15 million of adult-use cannabis in the quarter, while rival Canopy Growth sold about $47.3 million, a 35% increase from the same period of 2020.